In this symposium, you will hear from esteemed speakers from industry, academia, biopharma, and contract research organizations (CRO) on how ultrasensitive SMC™ technology empowers their research.

Topics to be covered include:

• Advances in ultrasensitive immunoassay technology
• SMC™ utility in acceleration of drug development programs
• Pharmacokinetics & Pharmacodynamics (PK/PD) and Immunogenicity
• Profile of immunological biomarkers during muscle injury and recovery
• IFN-γ in serum/plasma as a biomarker for disease progression
• SARS-CoV-2 biomarkers and microbiome profile in patient’s saliva 

Join us online to learn and interact with our panel speakers in the live Q&A sessions and grab the opportunity to have a scientific discussion in the “Ask The Expert” session in the Networking Lounge. Also, check out our Exhibition Hall to explore our innovative and award-winning protein portfolio*.

At Merck, our purpose is to solve the toughest problems in life science by collaborating with the global scientific community. Through that, we aim to accelerate access to better health for people everywhere. We look forward to having you in this informative and timely event!

For Research Use Only. Not For Use In Diagnostic Procedures

*MilliporeSigma was named Protein Supplier of the Year 2021 by CiteAb

The life science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the U.S. and Canada